ERBB2 and neoplasm: Here, HER2-specific CAR-T cells were generated using a novel scFv (anti-HER2-13) through a non-viral PiggyBac transposon system, resulting in stable and robust CAR expression and enhanced specificity toward HER2-positive tumor cells in vitro and in vivo.